Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: Accuracy of whole-body MRI at 3-Tesla and FDG-PET-CT

European Radiology

Volumn 19, Issue 12, 2009, Pages 2965-2976

  Ng, Shu Hang ^a,b   Chan, Sheng Chieh ^a   Yen, Tzu Chen ^a   Chang, Joseph Tung Chieh ^a   Liao, Chun Ta ^a   Ko, Sheung Fat ^a   Wang, Hung Ming ^a   Wai, Yau Yau ^a   Wang, Jiun Jie ^a   Chen, Min Chi ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Computed tomography; Magnetic resonance imaging; Nasopharyngeal carcinoma; Positron emission tomography; Whole body

Indexed keywords

FLUORODEOXYGLUCOSE;

ADRENAL METASTASIS; AGED; ARTICLE; BONE METASTASIS; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISTANT METASTASIS; FALSE POSITIVE RESULT; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; WHOLE BODY MRI;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 71449090898     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-009-1504-5     Document Type: Article

References (46)

1. A Fandi M Altrun N Azli, et al. 1994 Nasopharyngeal cancer: epidemiology, staging, and treatment Semin Oncol 21 382 397 1:STN:280:DyaK2c3mvFKmtw%3D%3D 8209270
2. WI Wei JST Sham 2005 Nasopharyngeal carcinoma Lancet 365 2041 2054 10.1016/S0140-6736(05)66698-6 15950718 (Pubitemid 40812341)
3. SH Ng TC Chang SF Ko, et al. 1997 Nasopharyngeal carcinoma: MRI and CT assessment Neuroradiology 39 741 746 10.1007/s002340050499 1:STN:280: DyaK1c%2Fht1ertg%3D%3D 9351114 (Pubitemid 27425071)
4. P Olmi C Fallai S Colagrande G Giannardi 1995 Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography Int J Radiat Oncol Biol Phys 32 795 800 1:STN:280: DyaK2MzhtVahtA%3D%3D 7790266
5. K Sakata M Hareyama M Tamakawa, et al. 1999 Prognostic factors of nasopharynx tumors investigated by MR imaging and the value of MR imaging in the newly published TNM staging Int J Radiat Oncol Biol Phys 43 273 278 1:STN:280:DyaK1M7ltlehsg%3D%3D 10030249
6. JT Chang CY Lin TM Chen, et al. 2005 Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy Int J Radiat Oncol Biol Phys 63 1354 1360 10.1016/j.ijrobp.2005.05.042 16297716 (Pubitemid 41628029)
7. AW Lee WM Sze JS Au SF Leung, et al. 2005 Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience Int J Radiat Oncol Biol Phys 61 1107 1116 15752890
8. XB Liao YP Mao LZ Liu, et al. 2008 How does magnetic resonance imaging influence staging according to AJCC staging system for nasopharyngeal carcinoma compared with computed tomography? Int J Radiat Oncol Biol Phys 72 1368 1377 18455329
9. MB Kumar JJ Lu KS Loh, et al. 2004 Tailoring distant metastatic imaging for patients with clinically localized undifferentiated nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 58 688 693 14967421
10. JT Chang SC Chan TC Yen, et al. 2005 Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography Int J Radiat Oncol Biol Phys 62 501 507 1:CAS:528:DC%2BD2MXktFGhsL8%3D 15890593
11. TC Yen JT Chang SH Ng, et al. 2005 The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx J Nucl Med 46 405 10 15750151
12. SH Ng SC Chan TC Yen, et al. 2009 Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up Eur J Nucl Med Mol Imaging 36 12 22 10.1007/s00259-008-0918-7 18704401
13. AD King BB Ma YY Yau B Zee, et al. 2008 The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis Br J Radiol 81 291 298 10.1259/bjr/73751469 1:STN:280:DC%2BD1c7osFWhtQ%3D%3D 18344274 (Pubitemid 351702957)
14. A Gordin A Golz M Daitzchman, et al. 2007 Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management Int J Radiat Oncol Biol Phys 68 370 376 17324532
15. RE Walker SJ Eustace 2001 Whole-body magnetic resonance imaging: techniques, clinical indications, and future applications Semin Musculoskelet Radiol 5 5 20 10.1055/s-2001-12923 1:STN:280:DC%2BD3M3ntVOiug%3D%3D 11371332
16. F Schick 2005 Whole-body MRI at high field: technical limits and clinical potential Eur Radiol 15 946 959 10.1007/s00330-005-2678-0 15856252 (Pubitemid 41166727)
17. TC Lauenstein SC Goehde CU Herborn, et al. 2008 Whole-body MR imaging: evaluation of patients for metastases Radiology 233 139 148 10.1148/radiol. 2331030777
18. GG Lo V Ai KM Au-Yeung JK Chan KW Li D Chien 2008 Magnetic resonance whole body imaging at 3 Tesla: feasibility and findings in a cohort of asymptomatic medical doctors Hong Kong Med J 14 90 96 18382014
19. GP Schmidt B Wintersperger A Graser A Baur-Melnyk MF Reiser SO Schoenberg 2007 High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study Invest Radiol 42 449 459 10.1097/01.rli. 0000262089.55618.18 17507818 (Pubitemid 46788746)
20. WA Willinek HH Schild 2008 Clinical advantages of 3.0 T MRI over 1.5 T Eur J Radiol 65 2 14 10.1016/j.ejrad.2007.11.006 18162354
21. CK Kuhl F Traber HH Schild 2008 Whole-body high-field-strength (3.0-T) MR Imaging in Clinical Practice. Part I. Technical considerations and clinical applications Radiology 246 675 696 10.1148/radiol.2463060881 18309012
22. Y Ohno H Koyama M Nogami, et al. 2007 Whole-body MR imaging vs. FDG-PET: comparison of accuracy of M-stage diagnosis for lung cancer patients J Magn Reson Imaging 26 498 509 10.1002/jmri.21031 17729341 (Pubitemid 350194569)
23. G Antoch FM Vogt LS Freudenberg, et al. 2003 Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology JAMA 290 3199 206 10.1001/jama.290.24.3199 1:CAS:528:DC%2BD2cXjvVyr 14693872 (Pubitemid 38020681)
24. CU Herborn C Unkel FM Vogt S Massing TC Lauenstein A Neumann 2005 Whole-body MRI for staging patients with head and neck squamous cell carcinoma Acta Otolaryngol 125 1224 1229 10.1080/00016480510040128 16353407 (Pubitemid 41800877)
25. TC Lauenstein RC Semelka 2006 Emerging techniques: whole-body screening and staging with MRI J Magn Reson Imaging 24 489 98 10.1002/jmri.20666 16888774 (Pubitemid 44320550)
26. GP Schmidt AR Haug SO Schoenberg MF Reiser 2006 Whole-body MRI and PET-CT in the management of cancer patients Eur Radiol 16 1216 25 10.1007/s00330-006- 0183-8 16538426 (Pubitemid 43834707)
27. C Johnston S Brennan S Ford S Eustace 2006 Whole body MR imaging: applications in oncology Eur J Surg Oncol 32 239 246 10.1016/j.ejso.2005.09.018 1:STN:280:DC%2BD287lvF2ltg%3D%3D 16427246
28. DD Brennan T Gleeson LE Coate C Cronin D Carney SJ Eustace 2005 A comparison of whole-body MRI and CT for the staging of lymphoma AJR Am J Roentgenol 185 711 716 10.2214/AJR.05.5149 1:STN:280:DC%2BD2MvltlSmtw%3D%3D 16120924
29. HE Daldrup-Link C Franzius, et al. 2001 Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET AJR Am J Roentgenol 177 229 236 1:STN:280:DC%2BD3MznsFKluw%3D%3D 11418435
30. CA Yi KM Shin KS Lee, et al. 2008 Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging Radiology 248 632 642 10.1148/radiol.2482071822 18552311
31. Y Ohno H Koyama Y Onishi D Takenaka, et al. 2008 Non-small cell lung cancer: whole-body MR examination for M-stage assessment-utility for whole-body diffusion-weighted Imaging compared with integrated FDG PET/CT Radiology 248 643 654 10.1148/radiol.2482072039 18539889
32. A Baur-Melnyk S Buhmann C Becker, et al. 2008 Whole-body MRI versus whole-body MDCT for staging of multiple myeloma AJR Am J Roentgenol 190 1097 1104 10.2214/AJR.07.2635 18356461 (Pubitemid 351571514)
33. C Pfannenberg P Aschoff S Schanz, et al. 2007 Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma Eur J Cancer 43 557 564 10.1016/j.ejca.2006.11.014 17224266 (Pubitemid 46177588)
34. C Lin A Luciani E Itti C Haioun A Rahmouni 2007 Whole body MRI and PET/CT in haematological malignancies Cancer Imaging 7 S88 S93 10.1102/1470-7330.2007. 9004 17921084 (Pubitemid 350120940)
35. E Squillaci G Manenti S Mancino, et al. 2008 Staging of colon cancer: whole-body MRI vs. whole-body PET-CT-initial clinical experience Abdom Imaging 33 676 688 10.1007/s00261-007-9347-5 18373114
36. FY Liu JT Chang HM Wang, et al. 2006 [18F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging J Clin Oncol 24 599 604 10.1200/JCO.2005.03.8760 16446332 (Pubitemid 46630422)
37. J Brouwer R de Bree OS Hoekstra, et al. 2005 Screening for distant metastases in patients with head and neck cancer: is chest computed tomography sufficient? Laryngoscope 115 1813 1817 10.1097/01.mlg.0000174954.51514.b7 16222201 (Pubitemid 41475895)
38. CR Leemans R Tiwari JJ Nauta I van der Waal GB Snow 1993 Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma Cancer 71 452 456 10.1002/1097-0142(19930115)71: 2<452::AID-CNCR2820710228>3.0.CO;2-B 1:STN:280:DyaK3s7jslWqsQ%3D%3D 8422638 (Pubitemid 23021234)
39. CE Metz 1986 ROC methodology in radiologic imaging Invest Radiol 21 720 733 10.1097/00004424-198609000-00009 1:STN:280:DyaL2s%2Fjt1Oqtw%3D%3D 3095258
40. JA Hanley BJ McNeil 1983 A method of comparing the areas under receiver operating characteristic curves derived from the same cases Radiology 148 839 843 1:STN:280:DyaL3s3nsVKgtg%3D%3D 6878708
41. GP Schmidt A Baur-Melnyk P Herzog, et al. 2005 High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system Invest Radiol 40 743 753 10.1097/01.rli.0000185878.61270.b0 16304476 (Pubitemid 41690430)
42. GP Schmidt SO Schoenberg MF Reiser A Baur-Melnyk 2005 Whole-body MR imaging of bone marrow Eur J Radiol 55 33 40 10.1016/j.ejrad.2005.01.019 1:STN:280:DC%2BD2MzgtlWksQ%3D%3D 15950099 (Pubitemid 40798486)
43. GP Schmidt SO Schoenberg R Schmid, et al. 2007 Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT Eur Radiol 17 939 949 10.1007/s00330-006-0361-8 16951929 (Pubitemid 46766875)
44. TC Lauenstein SC Goehde CU Herborn, et al. 2002 Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: a feasibility study AJR Am J Roentgenol 179 445 449 12130448
45. BB Frericks BC Meyer P Martus M Wendt KJ Wolf F Wacker 2008 MRI of the thorax during whole-body MRI: evaluation of different MR sequences and comparison to thoracic multidetector computed tomography (MDCT) J Magn Reson Imaging 27 538 545 10.1002/jmri.21218 18224677 (Pubitemid 351354738)
46. MJ Gollub R Hong DM Sarasohn T Akhurst 2007 Limitations of CT during PET/CT J Nucl Med 48 1583 1591 10.2967/jnumed.107.043109 17873133 (Pubitemid 47572704)